DI VEROLI, AMBRA
 Distribuzione geografica
Continente #
NA - Nord America 3.892
AS - Asia 664
EU - Europa 554
Continente sconosciuto - Info sul continente non disponibili 108
SA - Sud America 89
AF - Africa 9
OC - Oceania 1
Totale 5.317
Nazione #
US - Stati Uniti d'America 3.860
SG - Singapore 282
IT - Italia 179
CN - Cina 107
RU - Federazione Russa 90
BD - Bangladesh 79
BR - Brasile 74
HK - Hong Kong 70
IE - Irlanda 54
UA - Ucraina 46
VN - Vietnam 45
DE - Germania 42
FR - Francia 31
SE - Svezia 31
KR - Corea 28
GB - Regno Unito 23
JP - Giappone 22
FI - Finlandia 13
PL - Polonia 13
CA - Canada 12
IN - India 9
MX - Messico 9
ES - Italia 7
NL - Olanda 5
AT - Austria 4
PE - Perù 4
CO - Colombia 3
ID - Indonesia 3
JM - Giamaica 3
LT - Lituania 3
MA - Marocco 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AR - Argentina 2
BE - Belgio 2
CL - Cile 2
CU - Cuba 2
DO - Repubblica Dominicana 2
KE - Kenya 2
MD - Moldavia 2
MY - Malesia 2
PH - Filippine 2
SA - Arabia Saudita 2
SN - Senegal 2
TR - Turchia 2
VE - Venezuela 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
GD - Grenada 1
GP - Guadalupe 1
GT - Guatemala 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MM - Myanmar 1
NP - Nepal 1
PK - Pakistan 1
PR - Porto Rico 1
PY - Paraguay 1
QA - Qatar 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 5.211
Città #
Wilmington 1.017
Woodbridge 710
Houston 705
Fairfield 164
Chandler 160
Singapore 153
Ashburn 133
San Jose 84
New York 70
Hong Kong 66
Ann Arbor 65
Rome 63
Seattle 60
Cambridge 49
Council Bluffs 49
Dublin 48
Beijing 43
Medford 36
Los Angeles 26
Dearborn 23
Jacksonville 22
The Dalles 19
Buffalo 17
Santa Clara 17
Tokyo 17
Ho Chi Minh City 16
Lauterbourg 16
Lawrence 16
Center 13
Munich 11
Moscow 10
Milan 9
San Diego 9
Boardman 8
Dallas 8
Frankfurt am Main 8
Menlo Park 8
Orem 7
Warsaw 7
Guangzhou 6
Hanoi 6
London 6
Nanjing 5
Redwood City 5
Toronto 5
Atlanta 4
Brooklyn 4
Chicago 4
Da Nang 4
Hackensack 4
Helsinki 4
North Bergen 4
Philadelphia 4
Redondo Beach 4
São Paulo 4
Andong 3
Avellino 3
Colorado Springs 3
Dhaka 3
Hefei 3
Las Vegas 3
Lima 3
Mexico City 3
Naples 3
Nuremberg 3
Phoenix 3
Phủ Lý 3
Pignola 3
Pobbia 3
Seoul 3
Shanghai 3
Stockholm 3
Turku 3
Zhengzhou 3
Agawam 2
Bari 2
Bogotá 2
Brussels 2
Canoas 2
Castiglione Cosentino 2
Chennai 2
Chisinau 2
Columbus 2
Creede 2
Cuneo 2
Curitiba 2
Dakar 2
DeRidder 2
Dong Ket 2
Elmhurst 2
Engelhard 2
Fuzhou 2
Haiphong 2
Havana 2
Itaboraí 2
Jakarta 2
Johannesburg 2
Kingston 2
Kraków 2
Lancaster 2
Totale 4.144
Nome #
Recurrence of a t(8;21)-positive acute myeloid leukemia in the form of a granulocytic sarcoma involving cranial bones: a diagnostic and therapeutic challenge 441
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia 432
Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications 409
Treatment of low-blast count AML using hypomethylating agents 395
Reversible hyporegenerative anemia during natalizumab treatment 392
Minimal residual disease as a biomarker for outcome prediction and therapy optimization in acute myeloid leukemia 357
The emerging role of measurable residual disease detection in AML in morphologic remission 330
Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients 321
Cytotoxicity and differentiating effect of the poly(ADP-ribose) polymerase inhibitor olaparib in myelodysplastic syndromes 319
Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes 318
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors 279
Quality-of-life monitoring during hematopoietic stem cell transplantation: observations and a suggestion from the rome transplant network quality of life working party 204
Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations 201
Luspatercept in lower-myelodysplastic syndromes (MDS): Real-world data from the Gruppo Romano-Laziale Mielodisplasie (GROM-L) and review of literature 155
Azacytidine for the treatment of retrospective analysis from the Gruppo Laziale for the study of Ph-negative MPN 137
SARS‐CoV‐2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience 114
Diabetic retinopathy and age-related macular degeneration: A survey of pharmacoutilization and cost in Calabria, Italy 114
CD34 + CD38-CLL1+ leukemic stem cells persistence measured by multiparametric flow cytometry is a biomarker of poor prognosis in adult patients with acute myeloid leukemia 105
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide 101
Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience 91
La persistenza di cellule staminali leucemiche misurata mediante citofluorimetria multiparametrica è un biomarcatore prognostico per l’outcome dei pazienti adulti con leucemia acuta mieloide 63
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351 31
Real-world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial 8
Totale 5.317
Categoria #
all - tutte 15.356
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.356


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022180 0 12 15 5 3 25 9 16 3 20 14 58
2022/2023367 36 34 39 36 31 63 48 23 36 8 4 9
2023/2024154 19 9 9 3 10 55 2 5 1 2 5 34
2024/2025388 8 49 28 26 14 45 43 12 72 23 47 21
2025/2026982 88 42 98 102 87 35 107 113 96 76 43 95
2026/2027110 51 59 0 0 0 0 0 0 0 0 0 0
Totale 5.317